Biotech · Private company
Cortendo AB
Track this companyFree. Adds Cortendo AB to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- LevoketoconazolePhase 3 · Endogenous Cushing's SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- LevoketoconazolePhase 3 · Cushing SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- KetoconazolePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- levoketoconazolePhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- LevoketoconazolePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Levoketoconazole 150 - 600 mg (BID)Phase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- Metformin 500 mg Oral TabletPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Bioavailability of Levoketoconazole and Ketoconazole TabletsPHASE1 · COMPLETED · started Dec 16, 2019ClinicalTrials.gov NCT04212000 · fetched Nov 12, 2026
- Drug Interaction Study of Levoketoconazole and MetforminPHASE1 · COMPLETED · started Mar 28, 2019ClinicalTrials.gov NCT03880825 · fetched Nov 12, 2026
- Open-label Treatment in Cushing's SyndromePHASE3 · COMPLETED · started Jan 7, 2019ClinicalTrials.gov NCT03621280 · fetched Nov 12, 2026
- Levoketoconazole Food Effect Study in Healthy SubjectsPHASE1 · COMPLETED · started Nov 30, 2018ClinicalTrials.gov NCT03768388 · fetched Nov 12, 2026
- A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.PHASE3 · COMPLETED · started Sep 26, 2017ClinicalTrials.gov NCT03277690 · fetched Nov 12, 2026
- Treatment for Endogenous Cushing's SyndromePHASE3 · COMPLETED · started Aug 1, 2014ClinicalTrials.gov NCT01838551 · fetched Nov 12, 2026